VentureBeat March 20, 2024
In cardiovascular healthcare, innovation can mean the difference between life and death. FastWave Medical is at the forefront of this innovation, designing and developing novel intravascular lithotripsy (IVL) systems led by a fast-moving team dedicated to pioneering solutions for calcific artery disease. With a market valued at over $8 billion, the opportunities for growth and impact are immense.
FastWave has made significant progress in 2024, including the completion of enrollment in its first-in-human (FIH) study in mid-January, a significant milestone that garnered attention from numerous cardiovascular publications. Building on this early success, FastWave welcomed some of the world’s most prominent physicians to its advisor board in late January.
Investors can expect the release of the 30-day follow-up data from the...
Today's Sponsors
Today's Sponsor